| 000 | 01493 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512231139.0 | ||
| 264 | 0 | _c19840807 | |
| 008 | 198408s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/0014-2999(84)90238-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBokobza, B | |
| 245 | 0 | 0 |
_a[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMar 1984 |
||
| 300 |
_a167-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aButyrophenones _xmetabolism |
| 650 | 0 | 4 |
_aCaudate Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 |
_aNucleus Accumbens _xmetabolism |
| 650 | 0 | 4 |
_aParalysis _xmetabolism |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 |
_aPhenylacetates _xmetabolism |
| 650 | 0 | 4 |
_aPutamen _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xmetabolism |
| 650 | 0 | 4 |
_aSpiperone _xmetabolism |
| 650 | 0 | 4 |
_aSubstantia Nigra _xmetabolism |
| 700 | 1 | _aRuberg, M | |
| 700 | 1 | _aScatton, B | |
| 700 | 1 | _aJavoy-Agid, F | |
| 700 | 1 | _aAgid, Y | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 99 _gno. 2-3 _gp. 167-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0014-2999(84)90238-3 _zAvailable from publisher's website |
| 999 |
_c6734513 _d6734513 |
||